Efficacy and early complications of intravenous busulfan in children with thalassemia undergoing hematopoietic stem cell transplantation

Hematol Oncol Stem Cell Ther. 2008 Jul-Sep;1(3):189-92. doi: 10.1016/s1658-3876(08)50029-x.

Authors

Samart Pakakasama¹, Ampaiwan Chuansumrit, Butsakorn Damkong, Nongnuch Sirachainan, Somtawin Sirireung, Suradej Hongeng

Affiliation

¹ Faculty of Medicine Ramathibodi, Bangkok, Thailand. [email protected]

PMID: 20063551
DOI: 10.1016/s1658-3876(08)50029-x

No abstract available

MeSH terms

Busulfan / administration & dosage*
Busulfan / adverse effects
Child
Child, Preschool
Cyclophosphamide / administration & dosage
Female
Hematopoietic Stem Cell Transplantation*
Humans
Immunosuppressive Agents / administration & dosage*
Immunosuppressive Agents / adverse effects
Infant
Injections, Intravenous
Male
Transplantation Conditioning / methods*
beta-Thalassemia / surgery*

Substances

Immunosuppressive Agents
Cyclophosphamide
Busulfan